A detailed history of Rtw Investments, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 4,189,557 shares of AXSM stock, worth $364 Million. This represents 6.0% of its overall portfolio holdings.

Number of Shares
4,189,557
Previous 4,634,331 9.6%
Holding current value
$364 Million
Previous $373 Million 0.9%
% of portfolio
6.0%
Previous 6.23%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$78.93 - $95.84 $35.1 Million - $42.6 Million
-444,774 Reduced 9.6%
4,189,557 $376 Million
Q2 2024

Aug 14, 2024

BUY
$65.72 - $80.5 $9.31 Million - $11.4 Million
141,652 Added 3.15%
4,634,331 $373 Million
Q1 2024

May 15, 2024

BUY
$69.39 - $97.64 $213,929 - $301,024
3,083 Added 0.07%
4,492,679 $359 Million
Q3 2023

Nov 14, 2023

BUY
$69.25 - $82.21 $14.2 Million - $16.9 Million
205,319 Added 4.79%
4,489,596 $314 Million
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $29.4 Million - $45.5 Million
503,422 Added 13.32%
4,284,277 $308 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $46.7 Million - $60 Million
800,373 Added 26.85%
3,780,855 $233 Million
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $43.9 Million - $87.6 Million
1,098,318 Added 58.35%
2,980,482 $230 Million
Q3 2022

Nov 14, 2022

BUY
$36.06 - $69.85 $9.5 Million - $18.4 Million
263,345 Added 16.27%
1,882,164 $84 Million
Q4 2021

Feb 14, 2022

BUY
$30.7 - $43.36 $71,285 - $100,681
2,322 Added 0.14%
1,618,819 $61.2 Million
Q1 2021

May 14, 2021

SELL
$55.91 - $81.44 $3.13 Million - $4.55 Million
-55,919 Reduced 3.34%
1,616,497 $91.5 Million
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $98,006 - $127,876
1,478 Added 0.09%
1,672,416 $136 Million
Q3 2020

Nov 16, 2020

BUY
$68.34 - $85.84 $862,587 - $1.08 Million
12,622 Added 0.76%
1,670,938 $119 Million
Q2 2020

Aug 14, 2020

BUY
$49.87 - $98.69 $30.2 Million - $59.7 Million
605,347 Added 57.49%
1,658,316 $136 Million
Q1 2020

May 15, 2020

BUY
$41.2 - $101.31 $1.08 Million - $2.65 Million
26,156 Added 2.55%
1,052,969 $61.9 Million
Q4 2019

Feb 14, 2020

BUY
$16.71 - $106.24 $3.02 Million - $19.2 Million
180,692 Added 21.36%
1,026,813 $106 Million
Q3 2019

Nov 14, 2019

BUY
$20.24 - $29.16 $37,079 - $53,421
1,832 Added 0.22%
846,121 $17.1 Million
Q2 2019

Aug 14, 2019

BUY
$13.46 - $25.75 $3.35 Million - $6.4 Million
248,654 Added 41.75%
844,289 $21.7 Million
Q1 2019

May 15, 2019

BUY
$2.63 - $16.34 $1.57 Million - $9.73 Million
595,635 New
595,635 $8.48 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.